---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-078341"
form_type: "8-K"
ticker: null
cik: "0001673772"
company_name: "RAPT Therapeutics, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T08:15:24.977967+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# RAPT Therapeutics receives Nasdaq bid price deficiency notice; plans reverse stock split

## Summary
- Received Nasdaq notice on May 21, 2025: average closing bid price below $1.00 for 30 consecutive days.
- Has 180 days (until November 17, 2025) to cure by closing at $1.00 for 10 consecutive business days.
- Board approved 1-for-8 reverse stock split; stockholders vote on May 29, 2025 annual meeting.
- If not cured, may transfer to Nasdaq Capital Market or face delisting; appeal to Panel possible.

## SEC filing metadata
- accession: 0000950170-25-078341
- form_type: 8-K
- cik: 0001673772
- company_name: RAPT Therapeutics, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1673772/000095017025078341/0000950170-25-078341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1673772/000095017025078341/rapt-20250521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-078341
- JSON: https://secwatch.observer/filing/0000950170-25-078341.json
- Plain text: https://secwatch.observer/filing/0000950170-25-078341.txt

## Key facts
- Listing & Compliance Notices
  RAPT Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: May 21, 2025, RAPT Therapeutics, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the average closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the last 30 consecutive trading days (the “Notice”), as required for continued listing on the Nasdaq under Rule 5450(a)(1) of the Nasdaq’s Listing Rules (the “Rules”). The Notice has no immediate impact on the listing of the Company’s common stock, which will
  evidence_url: https://www.sec.gov/Archives/edgar/data/1673772/000095017025078341/0000950170-25-078341-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.